CD4+CD25+FOXP3+ Tregs are associated with poor prognosis in patients with ESCC, suggesting that CD4+CD25+FOXP3+ Tregs are crucial for enhancing the invasive ability of TC and facilitating tumor escape. This evidence concerns the gene FOXP3 and neoplasm.